70 related articles for article (PubMed ID: 1501889)
1. Rapid, complete and reversible transformation by v-sis precedes irreversible transformation.
Mercola D; Carpenter PM; Grover-Bardwick A; Mercola M
Oncogene; 1992 Sep; 7(9):1793-803. PubMed ID: 1501889
[TBL] [Abstract][Full Text] [Related]
2. Reversible transformation by v-sis: a model cell line for analysis of transformation by antisense methods.
Carpenter PM; Mercola M; Mercola D
Antisense Res Dev; 1991; 1(3):289-95. PubMed ID: 1821651
[TBL] [Abstract][Full Text] [Related]
3. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.
Huang RP; Darland T; Okamura D; Mercola D; Adamson ED
Oncogene; 1994 May; 9(5):1367-77. PubMed ID: 8152797
[TBL] [Abstract][Full Text] [Related]
4. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
Sonobe MH; Bravo R; Armelin MS
Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
6. Transformation of diploid human fibroblasts by DNA transfection with the v-sis oncogene.
Fry DG; Milam LD; Maher VM; McCormick JJ
J Cell Physiol; 1986 Aug; 128(2):313-21. PubMed ID: 3015989
[TBL] [Abstract][Full Text] [Related]
7. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
[TBL] [Abstract][Full Text] [Related]
8. v-myc and v-raf act synergistically to induce B-cell tumors in pristane-primed adult BALBC mice.
Kurie JM; Morse HC; Principato MA; Wax JS; Troppmair J; Rapp UR; Potter M; Mushinski JF
Oncogene; 1990 Apr; 5(4):577-82. PubMed ID: 2183159
[TBL] [Abstract][Full Text] [Related]
9. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).
Thomassen DG; Gilmer TM; Annab LA; Barrett JC
Cancer Res; 1985 Feb; 45(2):726-32. PubMed ID: 2981612
[TBL] [Abstract][Full Text] [Related]
10. The sis gene and PDGF.
Williams LT
Cancer Surv; 1986; 5(2):233-41. PubMed ID: 3536086
[TBL] [Abstract][Full Text] [Related]
11. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
12. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus.
Blasi E; Radzioch D; Merletti L; Varesio L
Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237
[TBL] [Abstract][Full Text] [Related]
13. V-sis gene (SSV) is expressed transiently and independently of v-gag (SSAV) after infection of fibroblasts with SSV/SSAV.
Schätzl HM; von der Helm K
Oncogene; 1989 Sep; 4(9):1095-101. PubMed ID: 2550873
[TBL] [Abstract][Full Text] [Related]
14. Invasiveness and chemotactic activity of oncogene transformed NIH/3T3 cells.
Melchiori A; Carlone S; Allavena G; Aresu O; Parodi S; Aaronson SA; Albini A
Anticancer Res; 1990; 10(1):37-44. PubMed ID: 2334141
[TBL] [Abstract][Full Text] [Related]
15. Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.
Maher DW; Strawn LM; Donoghue DJ
Oncogene; 1993 Mar; 8(3):533-41. PubMed ID: 8437840
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effects of heparin on normal and transformed NIH/3T3 fibroblasts.
Cavari S; Ruggiero M; Vannucchi S
Cell Biol Int; 1993 Aug; 17(8):781-6. PubMed ID: 8106075
[TBL] [Abstract][Full Text] [Related]
17. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
[TBL] [Abstract][Full Text] [Related]
18. Transformation-specific pattern of phosphorylation of c-Jun, Jun-B, Jun-D and Egr-1 in v-sis transformed cells.
Grover-Bardwick A; Adamson E; Mercola D
Carcinogenesis; 1994 Aug; 15(8):1667-74. PubMed ID: 8055649
[TBL] [Abstract][Full Text] [Related]
19. Expression of growth-related genes during tumor progression in v-raf-transformed rat liver epithelial cells.
Hampton LL; Worland PJ; Yu B; Thorgeirsson SS; Huggett AC
Cancer Res; 1990 Dec; 50(23):7460-7. PubMed ID: 1701345
[TBL] [Abstract][Full Text] [Related]
20. CD44 protein levels and its biological activity are regulated in Balb/c 3T3 fibroblasts by serum factors and by transformation with the ras but not with the sis oncogene.
Kogerman P; Sy MS; Culp LA
J Cell Physiol; 1996 Nov; 169(2):341-9. PubMed ID: 8908201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]